Cover of: Hypertrophic Cardiomyopathy | Barry J. Maron Read Online
Share

Hypertrophic Cardiomyopathy For Patients, Their Families and Interested Physicians by Barry J. Maron

  • 40 Want to read
  • ·
  • 34 Currently reading

Published by Blackwell Publishing Professional .
Written in English

Subjects:

  • Cardiovascular medicine,
  • Coping with illness,
  • General,
  • Medical,
  • Family / Parenting / Childbirth,
  • Cardiology,
  • HEART_DISEASES,
  • MYOCARDIUM,
  • Medical / Cardiology

Book details:

The Physical Object
FormatPaperback
Number of Pages96
ID Numbers
Open LibraryOL9351168M
ISBN 100913848050
ISBN 109780913848050
OCLC/WorldCa47151511

Download Hypertrophic Cardiomyopathy

PDF EPUB FB2 MOBI RTF

Hypertrophic cardiomyopathy (HCM) is a condition in which a portion of the heart becomes thickened without an obvious cause. This results in the heart being less able to pump blood effectively. Symptoms vary from none to feeling tired, leg swelling, and shortness of breath. It Causes: Genetics, Fabry disease, Friedreich's ataxia, . Aug 05,  · Hypertrophic cardiomyopathy (HCM) is typically defined by the presence of unexplained left ventricular hypertrophy (LVH). Such LVH occurs in a non-dilated ventricle in the absence of other cardiac or systemic disease capable of producing the observed magnitude of increased LV wall thickness, such as pressure overload (e.g., long-standing hypertension, aortic stenosis) or . "The book Hypertrophic Cardiomyopathy: For patients, their families and interested physicians, Second Edition (ISBN: ) was written by Barry J. Maron, MD and Lisa Salberg. It is meant to be a guide for those living with and/or caring for those with hypertrophic cardiomyopathy (HCM). It was published in December by Blackwell Futura, and is pages long. Jan 26,  · Hypertrophic cardiomyopathy (HCM) is a global disease with cases reported in all continents, affecting people of both genders and of various racial and ethnic origins. Widely accepted as a monogenic disease caused by a mutation in 1 of 13 or more sarcomeric Cited by:

Hypertrophic cardiomyopathy (HCM) is a common genetic cardiomyopathy, is present in potentially as many as 1: individuals in the general population, and is caused by over mutations in at least 11 genes encoding proteins of the cardiac sarcomere. 1,2 This genetic diversity is largely responsible for the heterogeneous phenotypic expression associated with this disease, including the. An introduction to hypertrophic cardiomyopathy (HCM). Download a PDF version. HCM is a condition where areas of heart muscle become thickened and stiff. The thickening makes it harder for the heart to contract and pump blood out to the body. This book provides a comprehensive clinical review of Hypertrophic Cardiomyopathy (HCM), the most common genetic disorder of the heart characterized by dysfunctional contractility at the sarcomere level, resulting in the development of abnormal and occasionally focal hypertrophy on a macroscopic. Hypertrophic cardiomyopathy (HCM) is an inherited disease of your heart muscle, where the muscle wall of your heart becomes thickened. HCM is a genetic condition caused by a change or mutation in one or more genes and is passed on through families. Each child of someone with HCM has a 50 per cent.

Jul 08,  · Hypertrophic cardiomyopathy (HCM) is a common inherited heart disease with diverse phenotypic and genetic expression, clinical presentation, and natural history. HCM has been recognized for 55 years, but recently substantial advances in diagnosis and treatment options have evolved, as well as increased recognition of the disease in clinical practice. Nevertheless, most genetically and Cited by: Diagnosis and Management of Hypertrophic Cardiomyopathy is a unique, multi-authored compendium of information regarding the complexities of clinical and genetic diagnosis, natural history, and management of hypertrophic cardiomyopathy (HCM)—the most common and important of the genetic cardiovascular diseases—as well as related issues impacting the health of trained athletes. Hypertrophic Cardiomyopathy. Hypertrophic cardiomyopathy is a concentric thickening of the left ventricular wall not caused by a downstream obstruction that can lead to both a fixed and a dynamic obstruction to left ventricular outflow (see Chapter 16). A large septal muscular prominence can lead to mitral regurgitation secondary to abnormal. Cardiomyopathy is an ongoing disease process that damages the muscle wall of the lower chambers of the heart. Hypertrophic cardiomyopathy is a form of cardiomyopathy in which the walls of the heart's chambers thicken abnormally. Other names for hypertrophic cardiomyopathy are idiopathic hypertrophic subaortic stenosis and asymmetrical septal hypertrophy.